Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide has a half-life of roughly five to seven days, which means it takes around five weeks for the medicine to leave your system after your last dose. You may notice appetite returning, and any nausea or other side effects fading, during that same window. These are prescription-only medicines and any decision about stopping, pausing or switching should be made with a prescriber, not guessed at. Understanding the timeline helps you plan sensibly — whether you're preparing for a procedure, thinking about trying for a baby, or just curious about what happens when treatment ends.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've taken your last Wegovy injection on a Tuesday. Nothing dramatic happens on Wednesday. By the end of the first week, blood levels of semaglutide have roughly halved; by the end of the second, halved again. The medicine doesn't vanish overnight, it steps down in a predictable curve shaped by that five-to-seven-day half-life.
In practical terms, most pharmacologists consider a drug effectively cleared after five half-lives. For semaglutide, that puts full clearance somewhere between five and seven weeks from the last dose. You can read more about how the medicine behaves over time on our detailed page covering how long Wegovy stays in your system.
What changes in the meantime? Gastric emptying, which semaglutide slows considerably, starts returning to its normal pace fairly quickly. Appetite follows. Many people find the familiar hunger signals begin nudging back within the first two weeks, sometimes sooner, and if you want a week-by-week sense of the timeline, our page on how long till Wegovy is out of your system walks through exactly what to expect. Side effects (particularly nausea, if you still had any) tend to ease off at a similar pace as levels drop. The NHS medicines page on semaglutide gives a solid grounding in how the medicine works and what to expect.
One thing worth knowing: the clearance timeline is broadly the same whether you were using the weekly injection or the newer daily Wegovy tablet, because the semaglutide molecule itself is identical. The route changes; the half-life doesn't shift dramatically.
The five-week clearance period isn't just a pharmacology curiosity. It has real consequences for specific situations, and getting the timing wrong can matter.
Pregnancy is the clearest example. Semaglutide is not recommended during pregnancy, while breastfeeding, or in the months when you're actively trying to conceive. UK and NHS guidance is explicit: use contraception throughout treatment and for a period after stopping before trying for a baby. If you are planning ahead, our page on how long until semaglutide is out of your system gives a clear breakdown of the timeline to help you and your prescriber plan the right gap. The exact recommended gap should come from your prescriber, who can factor in your full medical picture. This is not a decision to shortcut.
Surgery is another context where clearance timing comes up regularly. Anaesthetists need to know you've been on a GLP-1 medicine because slowed gastric emptying raises aspiration risk under general anaesthetic. NHS England advises telling your surgical and anaesthetic team well in advance (ideally at the pre-assessment appointment) so they can advise on timing. If you have a procedure coming up, our FAQs cover common practical questions and you can also speak directly with the team.
There's also the question of what to do with your appetite once the medicine is clearing. The hunger that returns as semaglutide washes out isn't a sign that something has gone wrong; it's the medicine's effect unwinding. Planning for that (practically and with support) is the part most people underestimate. If you're wondering how to approach the end of treatment, our weight-loss treatment overview sets out what a well-supported programme looks like.
This is the question a lot of people are really asking when they search for the clearance timeline. How quickly will the weight come back?
The honest answer, backed by the clinical trial data, is that weight regain after stopping semaglutide is common and can be significant. The STEP 1 trial, published in the New England Journal of Medicine, showed that participants who stopped semaglutide after 68 weeks regained a large proportion of lost weight within the following year. This isn't a failure of the person; it reflects that the medicine was doing a biological job (suppressing appetite, reducing food reward signals) and removing it removes that effect.
The speed of regain varies between individuals, but the direction is consistent without behavioural support in place. Protein intake, strength-based activity and continuing with the dietary habits built during treatment all help slow the curve. They don't halt it entirely, which is why many prescribers discuss long-term treatment rather than a fixed course.
If you're thinking about cost alongside this (specifically whether continuing treatment makes financial sense) our Wegovy cost page sets out what private treatment involves and what to weigh up. Worth reading before making a decision either way.
The Wegovy tablet (oral semaglutide, approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management) uses the same semaglutide molecule as the weekly injection. The absorption mechanism differs: the tablet uses an enhancer called SNAC to allow semaglutide to pass through the stomach wall, and it's taken daily rather than weekly.
Because the tablet is taken every day rather than once a week, blood levels may behave slightly differently during clearance than with the injection's single weekly depot. That said, the fundamental half-life of semaglutide itself hasn't changed, and our page on how long Wegovy is out of your system covers both formats if you want to compare the timelines side by side. For most practical planning purposes (surgery timing, contraception decisions, expecting appetite to return) the same rough five-week clearance window applies. Your prescriber is the right person to give you a more precise timeline if your situation requires it.
For a broader look at how semaglutide works and what to expect from treatment, the Wegovy treatment page covers the full picture. And if you'd like a prescriber to look at your specific timing question, starting a free consultation takes a few minutes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.